Metacrine News

Metacrine | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)

Mar 24, 2023 17:29 ET

Metacrine | 8-K: Current report

Mar 24, 2023 17:28 ET

Metacrine | 4: Statement of changes in beneficial ownership of securities-Director Klassen Preston

Mar 24, 2023 12:35 ET

Metacrine | S-8 POS: S-8 POS

Mar 23, 2023 16:34 ET

Metacrine | S-8 POS: S-8 POS

Mar 23, 2023 16:32 ET

Metacrine | 8-K: Current report

Mar 23, 2023 16:31 ET

Metacrine | 8-K: Current report

Mar 15, 2023 17:20 ET

Metacrine | EFFECT: Others

Mar 8, 2023 00:15 ET

Metacrine | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 3, 2023 17:25 ET

Metacrine | 8-K: Current report

Mar 3, 2023 17:23 ET

Metacrine | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Mar 3, 2023 10:44 ET

Metacrine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(9.98%),Tang Capital Management, LLC(9.98%), etc.

Feb 14, 2023 16:00 ET

Metacrine | DEF 14A: Definitive proxy statements

Feb 13, 2023 08:30 ET

Metacrine | 8-K: Current report

Feb 9, 2023 16:06 ET

Metacrine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(15.9%),BML Investment Partners, L.P.(14.5%)

Feb 8, 2023 15:43 ET

Metacrine | 8-K: Current report

Feb 3, 2023 17:08 ET

Metacrine | 8-K: Current report

Feb 1, 2023 16:16 ET

Metacrine | 4: Statement of changes in beneficial ownership of securities

Jan 27, 2023 16:44 ET

Metacrine | 4: Statement of changes in beneficial ownership of securities

Jan 27, 2023 16:42 ET

Metacrine | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Jan 24, 2023 17:17 ET